Noninvasive neuroimaging is an advanced medical technology that uses imaging techniques such as MRI (magnetic resonance imaging) and CT (computed tomography) to observe an individual's brain without needing to open it up to the skull. It is a fast, noninvasive, and relatively painless way to observe the internal structure and functions of the brain. This medical technology is used to diagnose various neurological conditions, such as Alzheimer's disease, Parkinson's disease, stroke, brain tumours, and traumatic brain injuries. Noninvasive neuroimaging can also provide useful information about the effects of certain conditions on the brain, such as those caused by drug or alcohol use, or environmental factors. Noninvasive neuroimaging involves a simple process whereby the patient is placed in a scanner that uses magnetic fields and radio waves to produce detailed images of the brain. This scan produces a 3-dimensional map of the various structures and functions of the brain such as the cortical lobes, white matter, grey matter, and cerebrospinal fluid, as well as any disease states or injury. This information can be used to identify any structural or functional changes that may be occurring within the brain. Noninvasive neuroimaging has many advantages including a shorter scan time, lower cost, and the ability to track changes in a patient’s brain over time without repeated surgery. This technology is also becoming increasingly sophisticated, with the use of noninvasive techniques such as functional MRI (fMRI) and positron emission tomography (PET) becoming more common in clinical practice.
Title : Scalp acupuncture with functional electrical stimulation for the treatment children with autism spectrum disorder
Zhenhuan Liu, Guangzhou University of Chinese Medicine, China
Title : Perception and individuality in patient cases identifying the ongoing evolution of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
Ken Ware, NeuroPhysics Therapy, Australia
Title : A structure-based strategy to target pathogenic α-synuclein in Parkinson’s disease
Salvador Ventura, Autonomous University of Barcelona, Spain
Title : Rabies: Challenges in taming the beast
Alan C Jackson, University of Calgary, Canada
Title : Designing and managing intelligent and ethical transformed health and social care ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Understanding Alzheimer's disease biomarkers across diverse populations - Opportunities and Insights for novel prevision medicine approaches
Sid O Bryant, Texas College of Osteopathic Medicine and University of North Texas Health Science Center Fort Worth, United States